desk
Share
Dr Reddy's informed after market close on Thursday that the company has recalled Levetiracetam in the US. The company said that the drug has been recalled due to incorrect labeling. According to the exchange filing, Dr. Reddy's Laboratories has announced the recall of a batch of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 mL) in the US due to a labeling error on the infusion bag.
The recall, which applies to lot number A1540076, was initiated after the infusion bags were incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection (500 mg/100 mL), while the aluminum overwrap correctly identified the product.
Health Risks from Mislabeling Mislabeling can pose a serious health risk, as patients receiving the drug may inadvertently receive twice the prescribed dose of levetiracetam, resulting in serious adverse effects. The affected batch was distributed to wholesalers across the country in the US between November 4 and November 6, 2024. Stock Performance The company's stock closed 0.11 per cent higher at Rs 1,106.35 on Thursday. The company's stock has declined 12.25 per cent in the last one year.
--Advertisement--
